An announcement was sent for FOCM Philadelphia area chapter to meet at Champps on Goddard Rd in King of Prussia, PA, just north of the big mall on August 19, 2013 from 6:00 to 8:00. The turnout was surprisingly good given my typical short notice (about 7 hours before the event) and the fact that *(&%^$ Philadephia traffic delayed my arrival until 6:30. Several new faces attended.
I was too busy talking, eating and drinking to remember any particular points of interest. We really must do it again sometime!
Author: Chris Matheus
New FDA Guidelines – Impact on Clinical Trials
submitted by FOCM Member Mark Mickunas
Here is an interesting article that appeared in the Raleigh News &
Observer on what I am currently involved in at work – Risk-based
Monitoring:
http://www.newsobserver.com/2013/08/15/3110740/new-fda-guidelines-could-benefit.html
FOCM RTP Chapter Networking Meeting Minutes – August 13, 2013
This is how it happened to the best of my recollection. An announcement was sent for FOCM RTP (Research Triangle Park, NC) chapter to meet at Serena’s on Miami Blvd in Durham on August 13, 2013 from 5:30 to 8:00. The Biotech Tuesday group was meeting there as well, so we chose to sit outside under an oscillating misting fan. First to arrive was Adam Chasse of RxTrials. RxTrials was just featured in FOCM’s first Company Spotlight earlier this week. You can check it out at this link: http://www.focmnetworking.com/focm-company-spotlight-rxtrials/
Subsequent arrivals were: Josh Davis, Greg Zak (Greg received his FOCM membership card in the customary traditional & formal ceremony), Phil & June Keicher (June received her FOCM membership card, also in the customary traditional & formal ceremony), Rosina Maar Pavia, Bill Newcomb, Andrew Smith, Mark Paul, Nick Macaulay and Vince Hoefling.
Many things were discussed, major global issues were resolved, but by then I forgot to write anything down, so we’ll have to reconvene at some point in the future.
FOCM Company Spotlight: RxTrials
RxTrials is an elite Integrated Site Network (ISN) and consulting/training firm focused on helping bring new treatments to patients that need them. Adam Chasse is the COO and a member of FOCM. Adam and Chris have known each other since the late 1990’s when both were working for Quintiles.
RxTrials’ multi-therapeutic network is comprised of private physician practices, while our consulting and training divisions provide guidance to sites, sponsors, and CROs to ensure efficient and high-quality study delivery. Our commitment today is the same as it has been since 1994; to set the standard for quality in study conduct and research site management services.
Doesn’t your study deserve to be one of the 10% that finish on time? Our industry is changing, and you need to ensure each element of your study is planned and executed precisely. No other industry service provider matches RxTrials’ combination of hands-on healthcare, clinical research, and study operations experience – contact us today to learn how we will deliver your next clinical trial.
Humor for Tuesday
submitted by FOCM Member Kevin Boos
Q – What do you call a midget psychic who just broke out of prison???
A – A small medium at large.
Afternoon joke
Submitted by FOCM Member Art Coppola
A dyslexic man walked into a bra….
Ice Cubes with hopes and dreams
submitted by FOCM Member Jon Matheus
I prefer crushed ice. It is difficult to enjoy a cool drink when your ice has hopes and dreams.
Today’s Humor
submitted by FOCM member Stuart Munson
A recent article in the Kentucky Post, reported that a woman, one Anne Maynard, has sued St. Luke’s hospital, saying that, after her husband had surgery there, he lost all interest in sex.
A hospital spokesman replied:
“Mr. Maynard was admitted in Ophthalmology – all we did was correct his eyesight.”
Do not overlook introverts
An interesting presentation on the value of the trait of introversion.
Interpersonal Communication – Things to watch for
I thought this was an interesting presentation on lying, from little white lies to large lies. Some body language clues and other non-verbal indicators of lying.